Skip to content

We find and validate mutations that others cannot

Search for:

Home
Mission
- Challenges in genomics: our solutions
Products
Posts
Purchase
- Pricing
Contact Us
About us
- Intellectual Property
- Applications
Resources
SiteMap

Menu

map

Pages

Posts

August 30, 2009
September 25, 2009
October 1, 2009
December 14, 2009
June 8, 2010.
April 24, 2012. Mutation interpretation in deep sequencing data
June 26, 2012. New US Patent
Oct 5, 2012. New Product: Shannon pipeline ….
October 17, 2012. Automating cytogenetic biodosimetry
November 7, 2012. Presentation at 2012 meeting of the American Society of Human Genetics.
January 4, 2013. Paper: “Predicting mRNA transcript isoforms derived from splicing mutations”, ASSEDA server
January 11, 2013. New paper accepted for publication in Nucleic Acids Research
November 12, 2012. Paper accepted for publication in Cytogenetics and Genomics
January 21, 2013. Paper about Shannon pipeline accepted for publication in Genomics, Proteomics, and Bioinformatics.
January 28, 2013. Platform presentation on Automated Dicentric Chromosome Identifier Software
February 1, 2013. Notice of Allowance on new US Patent on human genomic hybridization
February 3, 2013. New paper accepted for publication in IEEE Transactions in Biomedical Engineering
February 8, 2013. Trialing the Shannon Pipeline for mRNA Splicing Mutation Analysis.
February 26, 2013. Video published by the journal, “Human Mutation”
March 9, 2013. New Publication on Chromosome Centromere Detection in Metaphase Cell Images
March 15, 2013. Paper describing the Shannon pipeline for human mRNA splicing mutation analysis.
March 26, 2013. New US Patent issued.
March 26, 2013. New article published on chromosome centromere structure and composition.
April 4. Presentation at the Joint Conference of 2013 HGM & 21st International Congress of Genetics
Invitation to April 24th Webinar: Genome-scale mRNA Splicing Mutation analysis
Presentation at Human Genome Variation Society Meeting: Clinical Applications of Next Generation Sequencing
April 24, 2013. Webinar Presentation cosponsored by the Ontario Genomics Institute
Forthcoming presentations by Pete Rogan in Milan, Italy
April 29, 2013. Press release: US National Cancer Institute acquires Shannon Human Splicing Pipeline
May 22, 2013. Shannon mRNA splicing mutation pipeline version 1.0.5
July 19, 2013. Presentation to the Clinical Cancer Genetics group of the Italian Society of Human Genetics
Upcoming Invited Presentations
July 31, 2013. Paper accepted for oral presentation at the 63rd American Society of Human Genetics annual meeting
August 13, 2013. Paper accepted on evaluation of mutation prediction methods
September 6, 2013. Shannon pipeline highlighted at meeting on Clinical Applications of Next Generation Sequencing
September 16, 2013. US patent to be awarded on breakthrough radiation biodosimetry technology
September 19. Abstract on metaphase epigenetics: platform presentation at American Society of Human Genetics meeting
September 27, 2013. New release of Shannon pipeline for detection of mRNA splicing mutations
October 21. Platform presentation at ASHG using single copy FISH
October 25, 2013. Single copy FISH probes for metaphase epigenetic analysis
October 28, 2013. Presentation at the European Institute of Oncology
November 11, 2013. Presentation at the University of Milan
November 28. Presentation at the European Institute of Oncology
December 5, 2013. Breast Cancer Society of Canada Blog profiles our research
January 20, 2013. Canadian Breast Cancer Foundation highlights Early Breast Cancer Detection project based on Cytognomix technology
December 10, 2013. New patent on detecting biological exposure to radiation
December 10, 2013. Agreement to supply reagents for next generation sequencing
Jan. 10, 2014. Presentation at the The Fifth International Symposium on Hereditary Breast and Ovarian Cancer
Jan. 13, 2014. New paper and software for experimental evaluation of predicted mutations in genomes or exomes
Jan. 29, 2014. Translational Breast Cancer Research Retreat in London, Ontario
February 6, 2014. Biodosimetry manuscript accepted for publication
February 28, 2014. The Shannon splicing mutation software pipeline is online
March 3, 2014. Oral presentation at the The Fifth International Symposium on Hereditary Breast and Ovarian Cancer Conference
March 7, 2014. Veridical software paper indexed for PubMed and highlighted on the RNA-Seq Blog
March 9, 2014. Commentary on Mutation interpretation: current limitations and approaches to overcome them
April 9, 2014. Presentation at the American Association for Cancer Research meeting
April 22, 2014. New paper describing Automated Biodosimetry Software published
April 22, 2014. Validation of predicted splicing mutations paper in F1000Research – now in PubMed
May 5, 2014. Presentation at the Cancer Genome Atlas 3rd Annual Symposium
May 12-13, 2014. Presentation at the 3rd Cancer Genome Atlas Scientific Symposium
May 12-13, 2014. Cytognomix exhibiting at OCE Discovery, Toronto
May 14, 2014. Upcoming presentation at the 9th Annual Great Lakes Bioinformatics Conference
May 19, 2014. Veridical wins best paper award at two conferences!
May 23, 2014. A Comment about Variant Databases
June 12, 2014. New product announcement
July 13, 2014. Presentations at the 2014 American Society of Human Genetics Conference
July 23, 2014. New US patent application published on exon definition mutation analysis
July 30 2014. Invited presentation at Next Generation Sequencing conference
August 13, 2014. New Patent Application published
September 3, 2014. Technical presentation to US Patent and Trademark Office
October 14, 2014. New paper in press on the epigenetics of metaphase chromosomes
November 14, 2014. New paper on lymph node metastatic breast cancer uses MutationForecaster system
November 18, 2014. New review article on splicing mutation information analysis
November 18, 2014. Differential accessibility of scFISH probes to metaphase chromosomes published.
December 18, 2014. Best poster award for cytogenomics visual analytics decision support tool
December 30, 2014. Veridical software status update
January 17. MutationForecaster is launching…
February 2, 2015. The Cytognomix MutationForecaster system
February 8, 2015. Early adoption of the MutationForecaster system
February 25, 2015. Release of updated plugin Shannon splicing mutation pipeline software for Qiagen-CLC bio products
March 5, 2015. Interest in Mutation Forecaster™
March 17, 2015. Review article on mRNA splicing mutations highlighted on F1000Research blog
March 11, 2015. Invited presentation at the University of Ontario Institute of Technology
Feb. 20, 2015. Presentation at Schulich School of Medicine and Dentistry
March 27, 2015. Cover of the F1000Research webpage
April 3, 2015. Video tutorials available for MutationForecaster
April 6, 2015. New paper published on cancer of unknown primary
April 30, 2015. Sale of Shannon mRNA splicing mutation pipeline software license
April 30. Sale of MutationForecaster subscription
May 14, 2015. Presentation at the Great Lakes Chromosome Conference
May 21, 2015. Platform presentation at Compute Ontario Research Day
May 22, 2015. MutationForecaster receives US Trademark
April 18, 2015. New software distribution agreement for MutationForecaster
June 27, 2015. Best oral presentation at the 12th Annual London Oncology Research & Education Conference
July 3, 2015. New publication on breast cancer gene mutation
July 8, 2015. New paper using Cytognomix’s single copy FISH probes
July 11, 2015. Presentation at RegGen Satellite Meeting at 2015 ISMB Annual Meeting
July 31, 2015. Chemotherapy resistance in breast cancer manuscript accepted for publication
August 13, 2015. New paper on metaphase epigenetics published
Aug. 25, 2015. Top viewed article in Molecular Cytogenetics
August 28, 2015. Article on chemotherapy gene signature published
September 7, 2015. Video presentation of Molecular Oncology article on chemotherapy response
September 11, 2015. Final version of paclitaxel and gemcitabine chemotherapy signature paper now published
Sept. 18, 2015. Press release about chemotherapy resistance paper
September 24, 2015. MutationForecaster® now available on BaseSpace ecosystem!
September 27, 2015. Interview about breast cancer signature on CTV News, London
September 30, 2015. Illumina announces MutationForecaster on their BaseSpace blog
October 6, 2015. Presentations at the 2015 International EPR Biodose meeting
October 22, 2015. Presentation at the 2015 Toronto NGS Symposium
Presentation. 2015 Canadian Cancer Research Conference
Upcoming Presentation at University of Windsor, Ontario, Canada.
November 21, 2015. Literature based filtering in the MutationForecaster system
November 26, 2015. Splicing Mutation Calculator software
December 1, 2015. Presentation on chemotherapy response at Oncology Grand Rounds
December 14, 2015. Try MutationForecaster® for two weeks: Free of Charge!
December 17, 2015. Final version of machine learning-based chemotherapy response article is online
December 21, 2015. New capability in Cytognomix User Variation Database (CUVD)
December 23, 2015. “Filtering-in” gene variants for peer-reviewed evidence
January 16, 2016. Presentation at University of Western Ontario
January 17, 2016. MutationForecaster Workflow Updates.
Jan. 29, 2016. Updates to Cytognomix User Variation Database
February 6, 2016. Article accepted for publication on cytogenetic image analysis using machine learning
Feb. 15, 2016. Improved filtering in Mutation Forecaster for Variant Effect Predictor
February 16, 2016. New publication on inherited breast and ovarian cancer
Feb. 29, 2016. Publication on prioritizing variants in BRCA genes
March 1, 2016. Automated discrimination of dicentric chromosomes by machine learning
March 4, 2016. Presentation at Physics Rounds, London Regional Cancer Program
March 10, 2016. New paper accepted on prioritization strategy for gene variants of uncertain significance in breast/ovarian cancer
March 15, 2015. Funding from the Build-in-Canada Innovation Program
March 23, 2016. Final version of article about prioritizing mutations in inherited breast cancer is online
March 29, 2016. New publication on cost effectiveness of gene expression microarray testing in cancer diagnosis
April 11, 2016. New paper on analysis of variants of uncertain significance in hereditary breast & ovarian cancer
April 26, 2016. Grant funding received for chromosome structure studies using Cytognomix ab initio scDNA probes
April 28, 2016. Press release
April 30, 2015. Interview about BMC Medical Genomics and Human Mutation breast cancer articles
May 6, 2016. Upcoming public presentations
June 6, 2016. New paper on automated biodosimetry to be published
July 1, 2016. Article published on Centromere Detection in Human Metaphase Chromosomes
July 13, 2016. New publication on Automated Estimation of Radiation Exposure
July 29, 2016. The MutationForecaster Value Proposition
August 8-12, 2016. Presentation about metaphase chromosome epigenetics
August 31, 2016. New publication on predicting outcomes of hormone and chemotherapy in breast cancer
Sept. 23, 2016. Notice of Allowance of claims for US patent application
October 19, 2016. Publication in Atlas of Science for the layperson
November 28, 2016. Article on transcription factor binding sites published in Nucleic Acids Research
November 12, 2016. MutationForecaster detects mutations that alter transcriptional regulation
November 27, 2016. New patent issued in Germany
November 30, 2016. Contract award to Cytognomix by the Government of Canada.
December 1, 2016. Faux controversies in variant genomic analysis
December 6, 2016. Finding mutations in transcription factor binding sites with MutationForecaster
December 13, 2016. Postdoctoral Position available for high performance computing application in radiation biodosimetry
Jan. 23, 2017. Automated interpretation of digital pathology images is currently at an embryonic stage of development
January 25, 2017. Comment from the Transforming Genetic Medicine Initiative Blog
Jan. 28, 2017. New version of F1000Research paper on chemotherapy response in breast cancer
February 27, 2017. CytoGnomix finalizes contract with Government of Canada
March 31, 2017. New preprint on increased accuracy in radiation biodosimetry
April 8, 2017. Presentation about chemotherapy outcome prediction
April 18, 2017. US Patent 9,624,549 issued about chemotherapy target identification
May 4, 2017. CytoGnomix introducing new biodosimetry product
May 22, 2017. Protocol on automated radiation biodosimetry accepted for publication
June 1, 2017. Products delivered under the Build in Canada Innovation Program
June 3, 2017. Presentation at Variant Detection 2017
June 21, 2017. Landing page: Radiation.CytoGnomix.com
June 30, 2017. New publication on breast cancer genetics
July 5, 2017. MutationForecaster®: improved documentation
July 12, 2017. CytoGnomix exhibiting at 2017 American Society of Human Genetics Annual Conference
August 9, 2017. Publication on improved accuracy in radiation biodosimetry
August 24, 2017. Announcement of BCIP contract to CytoGnomix by the Government of Canada
September 3, 2017. New video protocol describing radiation biodosimetry software
Sept. 6, 2017. Article in Western News about Radiation Biodosimetry project
September 12, 2017. New publication on cancer of unknown primary
September 15, 2017. Projects featured in SHARCNET community update
October 4, 2017. Three upcoming presentations at the American Society of Human Genetics annual conference
CytoGnomix at the American Society of Human Genetics Annual Meeting Oct 17-21 2017
October 30, 2017. CytoGnomix signs agreement with International Atomic Energy Agency
November 11, 2017. ADCI software evaluation
November 20, 2017. New publication on inherited breast and ovarian cancer accepted for publication
December 1, 2017. New bespoke variant interpretation service
December 12, 2017. New preprint predicting response to platin drugs
Jan. 13 and 21, 2018. Comments on PubMed PMID 29280214: Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2, allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11.
Dec 12, 2017. Comment on PubMed PMID 23169495: Analysis of the effects of rare variants on splicing identifies alterations in GABAA receptor genes in autism spectrum disorder individuals.
Dec. 7, 2017. Rogan PK, Mucaki EJ. Comment on PMID 29185120: Characterization of a novel germline BRCA1 splice variant, c.5332+4delA. In: PubMed Commons [Internet]. Bethesda (MD): National Library of Medicine; 2017 Nov 28 [cited 2017 Dec 7].
Oct. 1, 2017. Comment on PubMed PMID 28949076: Rules and tools to predict the splicing effects of exonic and intronic mutations. In: PubMed Commons [Internet]. Bethesda (MD): National Library of Medicine; 2017 Sep 26
May 4, 2015. Comment on PMID 23348723. Prediction of mutant mRNA splice isoforms by information theory-based exon definition.
February 7, 2018. Accepted presentations at EPR Biodose (Munich, June, 2018)
February 19, 2018. Article on genomic signature of radiation exposure
February 28, 2018. New publication on radiation biodosimetry based upon machine learning
March 13, 2018. Oral presentation on chemotherapy response in Best Poster session at ESHG 2018
March 23, 2018. New preprint about target gene regulation by transcription factors
April 9, 2018. Upcoming release of Automated Dicentric Chromosome Identifier and Dose Estimator (ADCI)
March 29, 2018. Mutation Forecaster: Key to discovery of mutations in novel ALS gene
May 29, 2018. Change to cytognomix.org URL
May 30, 2018. Radiation gene signature study approved and indexed in PubMed.
June 7, 2018. Presentations at upcoming international conferences
June 13, 2018. Article in Fast Forward
Aug. 13, 2018. Differential accessibility to homologous chromosomal loci confirmed by international consortium
Sept. 11, 2018. New publication about promoter gene variants in BRCA1 and BRCA2 that alter gene expression
October 19, 2018. Presentations at the 7th Northeast Regional Chromosome Pairing Conference
November 6, 2018. Article on prediction of platin chemotherapy response accepted for publication
November 20, 2018. New preprint about splicing mutation beacon repository recognized as top genomics study
November 28, 2018. New automated cytogenetic biodosimetry article accepted for publication
December 7, 2018. New article describing database of validated mRNA splicing mutations published
December 14. New paper published about regulation of gene transcription by information theory and machine learning
January 11, 2019. Article on Prediction of platin chemotherapy response now available
January 9, 2019. Article on fully automated interpretation of the dicentric chromosome assay for radiation quantification now available
January 24, 2019. Updated version of CytoGnomix Visual Analytics (CytoVA) on MutationForecaster
Jan. 2019. CytoGnomix licenses ADCI software for radiation biodosimetry
Feb. 14, 2019. New article about targeted validation of mRNA splicing mutations
March 20, 2019. Presentation at the 2019 American College of Medical Genetics and Genomics annual conference
Pan-Cancer Splicing Web Beacon to be Presented at ACMG Meeting
April 11, 2019. New article about transcription factor binding site clusters, their role in target gene regulation and mutation analysis
May 8, 2019. Upcoming Platform presentation at the Association of Molecular Pathology-Global Congress
May 30, 2019. F1000Research splicing mutation database article now indexed in PubMed
June 28, 2019. Platform Presentation at 2019 ICRR on population-scale biodosimetry
July 4, 2019. Presentations describing interlaboratory comparison of radiation exposure determination by automated cytogenetic biodosimetry
July 31, 2019. New preprint on biodosimetry in BioRxiv
Aug. 19, 2019. Review article about machine learning for predicting chemotherapy response
Sept. 7, 2019. Pan cancer article and database update
Nov. 18, 2019. Final version of review article on prediction of chemotherapy response by machine learning now published
Feb. 11, 2020. Article about allele-specific alternative splicing published
April 24, 2020. Assessing radiation exposure across a population by geolocation
April 24, 2020. Schulich School of Medicine and Dentistry highlights PLOS ONE study on radiation dose estimation and COVID19
Geostatical Biodosimetry
July 13, 2020. New article on Virtual Molecular Tumor Boards from the Variants in Cancer Consortium
July 19, 2020. New analysis of SARS-CoV-2 cases in the United States
August 6, 2020. Updated: Geostatistical Analysis of SARS-CoV-2 Positive Cases in the United States
August 7, 2020. Publication of novel molecular mechanism of severe RNA-viral lung infections
August 14, 2020. Interview on Scientific Sense podcast
Aug. 31, 2020. Presentation at the 2020 American Society of Human Genetics meeting
August 31, 2020. Presentation on molecular mechanism of severe riboviral infections at the RiboClub Forum 2020
September 4, 2020. New article on automated partial body radiation exposure determination
New support for geostatistical analysis of COVID19 hotspots in Ontario
Nov. 9, 2020. Notice of Allowance for US Pat App. Ser. No. 16/057,710
Dec. 10, 2020. New article on chemotherapy response prediction
December 29, 2020. Coming soon… ADCI_Online
January 22, 2021. SHARCNET features publications by the Rogan laboratory
Feb. 9, 2021. Presentation at the International Atomic Energy Agency
Feb. 23, 2021. CytoGnomix receives new US Patent for radiation biodosimetry
March 29, 2021. Article describing accelerated biodosimetry by high performance computing
Platform presentation at ConRad 2021 on radiation gene signatures
Poster presentation at ConRad 2021 on radiation biodosimetry with ADCI
Lightning Presentation at “Healthcare without Boundaries” Colloquium – June 2, 2021
June 18, 2021. CytoGnomix is finalist in Innovation Forum (Cambridge UK) Entrepreneurship Global Accelerator
Aug. 24, 2021. New preprint: More sensitive and specific radiation gene expression signatures
MutationForecaster® Trademark renewed by US Patent and Trademark Office
October 5, 2021. New conference summary article from ConRad 2021 published
October 20, 2021. New article on metaphase epigenetics published in Molecular Cytogenetics journal
October 21, 2021. New article on radiation gene expression signatures in press
Dec. 8, 2021. New preprint about detecting COVID19 transmission earlier
Dec. 10, 2021. New preprint about automated radiation cytogenetic biodosimetry in population studies
September 9, 2022. Update on US Patent Application “Smart microscope system for radiation biodosimetry”
October 14, 2022. Interview with editors of F1000 Research about geospatial data analysis of COVID-19 study
October 17, 2022. Presentation at the International Symposium on the System of Radiological Protection (ICRP)
Nov. 1-3, 2022. Presentation at the International Atomic Energy Agency
Nov. 7-10, 2022. Presentation on population scale biodosimetry at International Symposium on the System of Radiological Protection
Nov. 15, 2022. New US Patent on radiation biodosimetry
Nov. 16, 2022. Article accepted about determination of radiation exposures using a worldwide cloud computing platform
Nov. 23, 2022. Our new handle to contact Peter Rogan and CytoGnomix
May 25, 2023. CytoGnomix to present at final RCP meeting of IAEA CRP E35010 (MEDBIODOSE)
Sept. 19, 2023. Democratizing ADCI as cloud-based software
Oct. 4, 2023. Radiobiology textbook published
January 25, 2024. Appreciation of Cytognomix’s COVID-19 research studies by the government of Ontario

Archives

Categories

biodosimetry
cytogenetics
FISH
News
product
- products
  - array Comparative Genomic Hybridization
Software
Standard
- Standard
Subtelomeric
- Subtelomeric
Targeted enrichment
Uncategorized

Sitemap created with WP Realtime Sitemap.

.

Written by: Peter Rogan on May 17, 2011.

Leave a Reply Cancel reply

You must be logged in to post a comment.

Products Search

Search for:

Recent Posts

January 25, 2024. Appreciation of Cytognomix’s COVID-19 research studies by the government of Ontario
Oct. 4, 2023. Radiobiology textbook published
Sept. 19, 2023. Democratizing ADCI as cloud-based software
May 25, 2023. CytoGnomix to present at final RCP meeting of IAEA CRP E35010 (MEDBIODOSE)

A SiteOrigin Theme